---
title: "Whole Genome Sequencing (WGS) Long Read Instruments & Consumables"
ocid: "ocds-h6vhtk-045a3f"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-045a3f"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-045a3f.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-045a3f.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "GENOMICS ENGLAND"
published: "2024-05-16"
---

# Whole Genome Sequencing (WGS) Long Read Instruments & Consumables

Buyer: GENOMICS ENGLAND  
Current stage: Award  
OCID: ocds-h6vhtk-045a3f

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-045a3f)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-045a3f.json)

## Summary

Genomics England has awarded a contract for the supply of Whole Genome Sequencing (WGS) Long Read Instruments & Consumables. The contract, with a total value of 3,067,524 GBP, was signed on 16th May 2024. The procurement method used was 'limited' and was negotiated without the publication of a contract notice. The buying organisation, Genomics England, aims to enable investigations into methylation, structural variant calling, and single nucleotide polymorphisms using native DNA sequencing for 1000 Cancer participant samples.

This tender presents an opportunity for businesses involved in the production and supply of laboratory reagents, medical consumables, and blood-testing reagents to engage with Genomics England. The contracting process is at the award stage, with Oxford Nanopore Technologies PLC being the active supplier. Businesses that offer long-read sequencing technology and related consumables would be well-suited to compete for this contract. The procurement is expected to open avenues for diagnostic advancements and drug discovery in cancer research within the NHS, providing significant growth opportunities for the selected supplier and potential subcontractors.

## Notice

The supply of instruments and consumables that provides a solution to enable investigations into methylation (5mC,5hmC), structural variant calling, copy number variant analysis and single nucleotide polymorphisms (SNP) detection, using native DNA sequencing for 1000 Cancer participant samples.

### Lot Information

Lot 1

Genomics England continues to explore long-read and methylation sequencing in cancer within the NHS and accurately to sequence genomes of under-represented and diverse ancestries with a view that this novel technology could open opportunities to identify not only known genomic features and aberrations but also those that are currently unidentifiable using existing sequencing technologies. This could facilitate immediate returns in diagnostic value to the NHS and reaping more meaningful rewards in the near future through more thorough analysis of the whole genome. Long-read analytical methods are still in their infancy, Genomics England is building a knowledge hub around the trusted research environment for individuals to train their methods; in turn these methods feed into the clinical pipeline of the future. Nurturing the research environment will permit the discovery of new diagnostic and prognostic markers as well as potential new targets for drug discovery to benefit patients in the future. Genomics England has a requirement to continue to purchase Long Read sequencing technology to fulfil its needs in relation to its Cancer Programme. The requirement is to provide sufficient sequencing instruments and necessary consumables and kit to meet the forecasts for the 3rd year of the Cancer programme through FY24/25. The requirement also includes appropriate support & maintenance and licenses required for operation. This relates to 1000 Cancer participant samples in this period. The requirement relates to continuing to purchase Oxford Nanopore Technologies (ONT) PromethION Flowcells to continue the study using the same technology.

### Procurement Information

The Contracting Authority (i) has a legal personality; (ii) is mainly funded by the Department of Health and Social Care; and (iii) has been established for the specific purpose of meeting needs in the general interest and does not have an industrial or commercial character and therefore meets the definition of a "body governed by public law" under the Public Contracts Regulations 2015 ("PCR"). The PCR covers "public contracts" which means contracts for pecuniary interest which have as their object the execution of works, the supply of products or the provision of services. The Contract is a goods or services contract under PCR, therefore, caught by the PCR and bound to follow public procurement rules. Regulation 32(2)(b)(ii) PCR describes the single operator exclusion and is the premise for this award without prior publication. This specific exclusion relates to a demonstration that only Oxford Nanopore Technologies PLC could deliver the goods and services described for technical reasons and reasons of scalability, where the goods and services cannot be obtained from any other economic operator to continue to deliver the programme using the same long read whole genome sequencing technology. The scope of requirements in this notice are the basis for this assessment. For technical reasons, it has been determined that Oxford Nanopore Technologies PLC are the only provider able to meet the justified requirements set out. Furthermore, they are also the only organisation able to deliver the requirement at the scale specified. Further details are provided within this notice and should be read in conjunction with this explanation. The Contracting Authority will enter into a contract with Oxford Nanopore Technologies Limited following the conclusion of a minimum 10-day standstill period from the date of issue of this notice. The 10-day standstill period will end on Tuesday 28th May 2024 at 11.59pm GMT, enabling a contract to be signed on Wednesday 29th May 2024.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/015641-2024 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Negotiated without publication of a contract notice |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 16 May 2024 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 15 May 2024 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £3,067,524 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | GENOMICS ENGLAND |
| Locality | LONDON |
| Post town | East London |
| Postcode | E14 5AB |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI42 Tower Hamlets |
| Local authority | Tower Hamlets |
| Electoral ward | Canary Wharf |
| Westminster constituency | Poplar and Limehouse |
| Delivery location | TLI London |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | OXFORD NANOPORE TECHNOLOGIES |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33140000 - Medical consumables
- 33190000 - Miscellaneous medical devices and products
- 33696200 - Blood-testing reagents
- 33696500 - Laboratory reagents

## Release History

- 16 May 2024 at 20:27 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/015641-2024

## Notice URLs

- http://www.genomicsengland.co.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-045a3f. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-045a3f.json.